Tag: FDA

How to Create a Hybrid Inspection Model

remote collaboration

Leveraging remote collaboration to augment existing inspection protocols. The pharmaceutical manufacturing industry is incredibly important to healthcare around the world. With growing pressure to produce affordable medication for growing patient populations in developed and developing nations alike, regulatory authorities must ensure that manufacturers deliver high-quality products while maintaining transparency across their entire lifecycle. Traditionally, this […]

Webinar: Preparing for FDA Remote Inspections

FDA remote inspections

Virtual Inspection Training & Preparing for FDA Remote Inspections Last month, the House Appropriations Committee released its budget for 2022, which includes a $257 million increase in funding for the FDA. What does this mean for your organization? And how can your team prepare for unannounced or remote inspections? Join Avatour and Regulatory Compliance Associates, […]

COVID’s Impact on Pharmaceutical Compliance

The pharmaceutical and medicine manufacturing industry is one of the most heavily regulated industries in the country. The FDA is charged with ensuring the safety of all medicines available to people of the United States. This alone is an incredibly difficult task. And with the advent of the COVID-19 pandemic, it’s only become more challenging.  […]